Rakovina Therapeutics Inc.
RKV.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.02M | -5.90M | -6.21M | -5.92M | -5.42M |
| Total Depreciation and Amortization | 390.40K | 389.30K | 384.80K | 383.30K | 384.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 847.60K | 692.90K | 624.70K | 592.10K | 282.00K |
| Change in Net Operating Assets | 1.37M | 987.70K | 1.03M | -117.10K | -579.70K |
| Cash from Operations | -2.41M | -3.83M | -4.18M | -5.06M | -5.33M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 600.00K | 0.00 | 0.00 | 0.00 | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.11M | 5.98M | 4.98M | 7.91M | 8.21M |
| Repurchase of Common Stock | -77.70K | -77.70K | -77.70K | -16.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 52.30K | -95.00K | -95.00K | -263.60K | -289.70K |
| Cash from Financing | 1.20M | 4.20M | 3.48M | 5.49M | 5.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.21M | 367.10K | -701.30K | 429.80K | 370.30K |